Kailash Prasad Prajapati

16PUBLICATIONS
5CO-AUTHORS
Industrial molecular engineering of nucleic acids and proteinsPolymerisation mechanismsPharmaceutical delivery technologiesMedical molecular engineering of nucleic acids and proteinsNanofabrication, growth and self assembly
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 31, 2026
Hen egg lysozyme fibrils act as amyloid nucleating agents for β-lactoglobulin and insulin.

Kailash Prasad Prajapati, Pranjali Yadav, Shikha Mittal

|Dec 12, 2025
Amyloid-Inducing Agents via Metabolite Self-Assembly Expands the Boundary of Prion Concept beyond Proteins.

Kailash Prasad Prajapati, Shikha Mittal, Masihuzzaman Ansari

|Aug 28, 2025
Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks.

Masihuzzaman Ansari, Kailash Prasad Prajapati, Shikha Mittal

|Mar 27, 2025
Targeting Lysozyme-Linked Amyloidosis through Piperine-Functionalized Gold Nanoparticles.

Anubhuti Bhatia, Nishant Mishra, Kailash Prasad Prajapati

|Feb 10, 2025
Fabricating Silver Nanoparticles with Antidiabetic d-Pinitol to Restrict Amyloid Formation of Insulin.

Om Prakash Mahato, Kailash Prasad Prajapati, Masihuzzaman Ansari

|Dec 02, 2024
Structural Conversion of Serotonin into Amyloid-like Nanoassemblies Conceptualizes an Unexplored Neurotoxicity Risk.

Kailash Prasad Prajapati, Shikha Mittal, Masihuzzaman Ansari

Pageof 3